Tiny sensors could revolutionize jaundice treatment for newborns
NCT ID NCT07057635
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a new wireless sensor that continuously measures the light dose babies receive during phototherapy for jaundice. Currently, doctors check light levels only once a day with a handheld device, which can be inaccurate. The sensor aims to provide real-time data to ensure babies get the right amount of treatment. Nine newborns in the NICU will be enrolled to compare the sensor's readings with standard measurements.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
wireless irradiance sensor (bilisensor)
What this could lead to
If successful, this could lead to better, real-time monitoring of phototherapy for newborns with jaundice, potentially improving treatment accuracy.
What could go wrong
This is a very small, early-stage study with only 9 participants, so results may not apply broadly. The device may have data gaps or accuracy issues.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEONATAL HYPERBILIRUBINEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Montreal Children's Hospital
Montreal, Quebec, H4A 3H9, Canada